title: Cyclosporine A blood levels predict acute rejections as well as cyclosporine A toxicity after simultaneous pancreas-kidney transplantation.
authors.affiliation: Department of Surgery, University of Texas Southwestern Medical Center, Dallas 75235-9031.
authors.forename: I
authors.initials: I
authors.lastname: Dawidson
authors.forename: A
authors.initials: A
authors.lastname: Ar'Rajab
authors.forename: C
authors.initials: C
authors.lastname: Lu
authors.forename: D
authors.initials: D
authors.lastname: Melone
authors.forename: D
authors.initials: D
authors.lastname: Provost
authors.forename: D
authors.initials: D
authors.lastname: Wheeler
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000097:blood* / Q000627:therapeutic use / Q000633:toxicity; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery*; D004334:Drug Administration Schedule; D006084:Graft Rejection / Q000175:diagnosis*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D016035:Pancreas Transplantation / Q000276:immunology* / Q000502:physiology; D011237:Predictive Value of Tests; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011241:Prednisone